24Mar 2026
High Burden of Symptomatic COPD Persists Despite Triple Therapy in China

High Burden of Symptomatic COPD Persists Despite Triple Therapy in China

A real-world study in China finds that nearly 29% of COPD patients on triple inhaled therapy remain highly symptomatic with frequent exacerbations. These patients, often older and with more severe symptoms, show only partial disease control. Findings highlight urgent unmet needs and the call for novel therapies and better guideline-based management.

  • #pulmonology

Like

Save

Share